Joseph H. Murray

Array ( [id] => 5585452 [patent_doc_number] => 20090104654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'LOW VOLATILITY HIGH TEMPERATURE TISSUE CONDITIONING CROSS-REFERENCE TO RELATED APPLICATION' [patent_app_type] => utility [patent_app_number] => 11/720705 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8536 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104654.pdf [firstpage_image] =>[orig_patent_app_number] => 11720705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748343 [patent_doc_number] => 20060111275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols' [patent_app_type] => utility [patent_app_number] => 11/295279 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12990 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111275.pdf [firstpage_image] =>[orig_patent_app_number] => 11295279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648343 [patent_doc_number] => 20060134075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Composition and method for improving function of embryonic kidney transplants' [patent_app_type] => utility [patent_app_number] => 11/285797 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10636 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134075.pdf [firstpage_image] =>[orig_patent_app_number] => 11285797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5421975 [patent_doc_number] => 20090148430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'HUMAN OBESITY SUSCEPTIBILTY GENE ENCODING POTASSIUM ION CHANNELS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/719827 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15069 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148430.pdf [firstpage_image] =>[orig_patent_app_number] => 11719827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740479 [patent_doc_number] => 20080234132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Microcin B17 Analogs And Methods For Their Preparation And Use' [patent_app_type] => utility [patent_app_number] => 11/667385 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 27959 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11667385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318711 [patent_doc_number] => 07521421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Deuterated cyclosporine analogs and methods of making the same' [patent_app_type] => utility [patent_app_number] => 11/280666 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10795 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521421.pdf [firstpage_image] =>[orig_patent_app_number] => 11280666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92200 [patent_doc_number] => 07737111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Peptides and related molecules that bind to TALL-1' [patent_app_type] => utility [patent_app_number] => 11/272521 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 22768 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737111.pdf [firstpage_image] =>[orig_patent_app_number] => 11272521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318717 [patent_doc_number] => 07521427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Peptidyl allyl sulfones' [patent_app_type] => utility [patent_app_number] => 11/270404 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13926 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521427.pdf [firstpage_image] =>[orig_patent_app_number] => 11270404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727480 [patent_doc_number] => 20060058240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Peptides and compounds that bind to a receptor' [patent_app_type] => utility [patent_app_number] => 11/254419 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22476 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058240.pdf [firstpage_image] =>[orig_patent_app_number] => 11254419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912347 [patent_doc_number] => 20060127409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Bcr-abl vaccines and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/250607 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24269 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127409.pdf [firstpage_image] =>[orig_patent_app_number] => 11250607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077021 [patent_doc_number] => 07615534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Antimicrobial peptides and use thereof' [patent_app_type] => utility [patent_app_number] => 11/247376 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7257 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615534.pdf [firstpage_image] =>[orig_patent_app_number] => 11247376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299988 [patent_doc_number] => 07538189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Methods of making deuterated cyclosporin analogs' [patent_app_type] => utility [patent_app_number] => 11/245775 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10797 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538189.pdf [firstpage_image] =>[orig_patent_app_number] => 11245775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289062 [patent_doc_number] => 07547676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Antagonist peptides to the C5A chemotactic function of vitamin D binding protein' [patent_app_type] => utility [patent_app_number] => 11/243960 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16806 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547676.pdf [firstpage_image] =>[orig_patent_app_number] => 11243960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632229 [patent_doc_number] => 20060148699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Counterion exchange process for peptides' [patent_app_type] => utility [patent_app_number] => 11/244135 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10578 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148699.pdf [firstpage_image] =>[orig_patent_app_number] => 11244135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648397 [patent_doc_number] => 20060134129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Synthetic HLA binding peptide analogues and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/238128 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17789 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134129.pdf [firstpage_image] =>[orig_patent_app_number] => 11238128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638042 [patent_doc_number] => 20060069016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Cyclosporin alkyne analogues and their pharmaceutical uses' [patent_app_type] => utility [patent_app_number] => 11/232360 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 34042 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069016.pdf [firstpage_image] =>[orig_patent_app_number] => 11232360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638041 [patent_doc_number] => 20060069015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Novel cyclosporin analogues and their pharmaceutical uses' [patent_app_type] => utility [patent_app_number] => 11/232292 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30997 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069015.pdf [firstpage_image] =>[orig_patent_app_number] => 11232292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808271 [patent_doc_number] => 20080171849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Peptide Cyclisation' [patent_app_type] => utility [patent_app_number] => 11/663276 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6776 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171849.pdf [firstpage_image] =>[orig_patent_app_number] => 11663276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916255 [patent_doc_number] => 20080096856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Antibiotic Compound' [patent_app_type] => utility [patent_app_number] => 11/661466 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8813 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096856.pdf [firstpage_image] =>[orig_patent_app_number] => 11661466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 202670 [patent_doc_number] => 07632805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Growth factor binding molecules' [patent_app_type] => utility [patent_app_number] => 11/226112 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13177 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632805.pdf [firstpage_image] =>[orig_patent_app_number] => 11226112 [rel_patent_id] =>[rel_patent_doc_number] =>)